Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Geary Richard S
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer O'NEIL PATRICK R.
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Schneider Eugene
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Swayze Eric
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Monia Brett P
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jenne Kyle
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer HOUGEN ELIZABETH L
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Baroldi Joseph
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer BENNETT C FRANK
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birchler Brian
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Devers Shannon L.
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hayden Michael R
Ionis Pharmaceuticals | 8-K: Current report
Ionis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(5.0%),Biotech Invest N.V.(5.0%)
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Swayze Eric
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Monia Brett P
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LOSCALZO JOSEPH
Ionis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(9.0%)
Ionis Pharmaceuticals | 144/A: Others
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144